Crispr Therapeutics - Company Information
Crispr therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary crispr/cas9 platform. crispr/cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic dna. crispr therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. to accelerate and expand its efforts, crispr therapeutics has established strategic collaborations with leading companies including bayer, vertex pharmaceuticals and viacyte, inc. crispr therapeutics ag is headquartered in zug, switzerland, with its wholly-owned u.s. subsidiary, crispr therapeutics, inc., and r&d operations based in cambridge, massachusetts, and business offices in san francisco, california and london, united kingdom.
Biotechnology
Crispr Therapeutics - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Crispr Therapeutics.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
Crispr Therapeutics - Company Information
Crispr therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary crispr/cas9 platform. crispr/cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic dna. crispr therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. to accelerate and expand its efforts, crispr therapeutics has established strategic collaborations with leading companies including bayer, vertex pharmaceuticals and viacyte, inc. crispr therapeutics ag is headquartered in zug, switzerland, with its wholly-owned u.s. subsidiary, crispr therapeutics, inc., and r&d operations based in cambridge, massachusetts, and business offices in san francisco, california and london, united kingdom.
Biotechnology
Crispr Therapeutics - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Crispr Therapeutics.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
